Your session is about to expire
← Back to Search
Coordinated Specialty Care for Psychosis (AC-EPINET Trial)
N/A
Recruiting
Led By Alan Breier
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Between 16 and 35 years of age
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
AC-EPINET Trial Summary
This trial will compare the effects of two types of cancer support services on engagement and outcomes.
Who is the study for?
This trial is for young individuals aged 16-35 who have recently been diagnosed with certain mental health conditions, including schizophrenia and bipolar disorder with psychotic features. Participants must be new to one of the six clinical programs, able to consent, and commit to the study schedule.Check my eligibility
What is being tested?
The study compares two ways of delivering Coordinated Specialty Care (CSC) for mental health: through telehealth (CSC-TH) versus standard in-clinic care (CSC-SD). The goal is to see which method keeps patients more engaged over a year.See study design
What are the potential side effects?
Since this trial focuses on service delivery methods rather than medication, side effects are not typical as seen with drug trials. However, participants may experience varying levels of comfort or satisfaction with the mode of therapy they receive.
AC-EPINET Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 16 and 35 years old.
AC-EPINET Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Annualized hospitalization rates
Secondary outcome measures
Number of participants hospitalized
Symptom and functioning outcomes assessed by the MIRECC-GAF
Time (days) to first hospitalization
AC-EPINET Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: CSC-THExperimental Treatment1 Intervention
Telehealth based CSC model treatment. Treatment will be delivered largely through telehealth for 12 months.
Group II: CSC-SDPlacebo Group1 Intervention
Standard clinic-based CSC model treatment. Treatment will be delivered largely in clinic for 12 months.
Find a Location
Who is running the clinical trial?
Vanderbilt UniversityOTHER
705 Previous Clinical Trials
6,143,243 Total Patients Enrolled
6 Trials studying Bipolar Disorder
1,682 Patients Enrolled for Bipolar Disorder
University of RochesterOTHER
845 Previous Clinical Trials
534,837 Total Patients Enrolled
1 Trials studying Bipolar Disorder
65 Patients Enrolled for Bipolar Disorder
University of MichiganOTHER
1,811 Previous Clinical Trials
6,384,608 Total Patients Enrolled
19 Trials studying Bipolar Disorder
3,034 Patients Enrolled for Bipolar Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 16 and 35 years old.My psychotic disorder started less than 5 years ago.
Research Study Groups:
This trial has the following groups:- Group 1: CSC-SD
- Group 2: CSC-TH
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger